|
FY2026
12 months to Mar 31, 2026
|
FY2025
12 months to Mar 31, 2025
|
FY2024
12 months to Mar 31, 2024
|
FY2023
12 months to Mar 31, 2023
|
FY2022
12 months to Mar 31, 2022
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net Loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Depreciation and amortization | |||||
| Amortization of right-to-use assets | |||||
| Depreciation | |||||
| Amortization of right-of-use assets | |||||
| Impairment of intangible asset | |||||
| Accretion expense | |||||
| Stock-based compensation | |||||
| Loss on disposal of property, plant & equipment | |||||
| Gain on debt extinguishment | |||||
| Other expense | |||||
| Foreign currency translation (gain) loss | |||||
| Net changes in operating assets & liabilities: | |||||
| Prepaid expenses and deposits | |||||
| VAT receivable | |||||
| Inventories | |||||
| Loan payable | |||||
| Accounts payable - related parties | |||||
| Deferred revenue | |||||
| Accounts payable and accrued liabilities | |||||
| Net cash used in operating activities | |||||
| Cash flows from investing activities: | |||||
| Investment - internally developed software | |||||
| Purchase of property, plant & equipment | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Lease payments | |||||
| Payments to related parties | |||||
| Proceeds from shares issuance for cash | |||||
| Proceeds from PIPE transaction | |||||
| Proceeds from warrant exercise | |||||
| Payments on note payable | |||||
| Net cash provided by financing activities | |||||
| Net change in cash | |||||
| Cash at beginning of year | |||||
| Cash at end of year | |||||
| Supplemental disclosure of cash flow information | |||||
| Interest | |||||
| Supplemental disclosure of non-cash investing and financing activities: | |||||
| Addition of Right-of-use assets | |||||
Loading...